- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 04.12. | Daiichi Sankyo receives FDA untitled letter taking aim at Turalio patient ambassador video | ||
| 04.12. | FDA leadership churn continues with transfer of OTC drug office director | ||
| 04.12. | A dozen former FDA commissioners blast Prasad's proposed vaccine policy changes | ||
| 04.12. | Quvara Medical debuts as latest CDMO after Buckland Group buys Becton Dickinson facility | ||
| 04.12. | After dodging Biosecure threat, WuXi AppTec faces new security scrutiny from Pentagon: Bloomberg | ||
| 03.12. | Cosmo shares zoom with results from 2 male-pattern hair loss trials | ||
| 03.12. | Daiichi Sankyo prevails on appeal in long-running ADC patent battle with Seagen, flipping prior $41.8M verdict | ||
| 03.12. | Johnson & Johnson directs a new campaign for aging eyes with Naomi Watts in the spotlight | ||
| 03.12. | With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis | ||
| 03.12. | Excelsior collects $95M on mission to accelerate discovery, production of small molecules | ||
| 03.12. | Workplaces labor to keep staff as fertility support falls short, Ferring survey finds | ||
| 02.12. | CDER head Richard Pazdur set to retire shortly after appointment | ||
| 02.12. | Incyte taps Winnie Harlow to model vitiligo awareness, empowerment in new campaign | ||
| 02.12. | Lawmakers dig in on biopharma manufacturing with bill proposing US center of excellence | ||
| 02.12. | House endorses bill that would revive FDA's rare pediatric review voucher program | ||
| 02.12. | Pharmas have promised $370B in US investments amid 2025's onshoring boom: DPR | ||
| 02.12. | Regulatory tracker: Eisai finalizes FDA filing for subcutaneous Leqembi starter dose | ||
| 01.12. | FDA's Prasad tells staffers agency plans to get tougher on vaccine regulation, blames child deaths on COVID shots | ||
| 01.12. | Tanabe Pharma shifts gears for Bain-backed future, dropping Mitsubishi moniker after $3.3B deal | ||
| 01.12. | Microsize, Schedio link to buy Lonza's Swiss micronization plant | ||
| 01.12. | Close of Omnicom-Interpublic megamerger brings new health CEO, 4K layoffs | ||
| 01.12. | In UK trade deal, Trump administration excludes drugs from tariffs and secures promise of more pharma investment | ||
| 01.12. | Lilly lowers self-pay prices of single-dose Zepbound vials | ||
| 26.11. | Medicare unveils price reductions for 15 drugs, including Novo's semaglutide | ||
| 26.11. | Novo cashes in FDA national priority voucher for extra-speedy review of high-dose Wegovy |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .